Suppr超能文献

超声内镜下胃印戒细胞癌两种不同表现形式的临床病理特征比较

The comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS.

作者信息

Liu Shanshan, Han Chaoqun, He Qi, Shang Guochen, Jin Yu, Liu Jun, Ding Zhen, Lin Rong

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.

Endoscopy Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province.

出版信息

Endosc Ultrasound. 2024 Sep-Oct;13(5):293-299. doi: 10.1097/eus.0000000000000085. Epub 2024 Nov 8.

Abstract

BACKGROUND AND OBJECTIVES

There are two different endoscopic ultrasonographic manifestations of gastric signet ring cell carcinoma (GSRCC). No studies have been reported on the differences in the clinical profiles of patients based on EUS examination. We aim to study the variations in clinicopathological characteristics between two distinct endoscopic ultrasonographic manifestations of GSRCC.

METHODS

A total of 302 patients with GSRCC confirmed by pathological examination who underwent EUS were enrolled in the study. Based on the endoscopic ultrasonographic features, patients were categorized into two groups: type 1, where the entire layer structure disappeared, and type 2, where the layer structure was still present and appeared lymphomatoid. Clinicopathologic features were collected retrospectively and analyzed.

RESULTS

Compared with type 2 patients, type 1 patients tended to develop GSRCC at an older age ( = 0.033) and had higher serum levels of tumor markers and were more likely to experience anemia ( < 0.001) and weight loss ( < 0.001) during the disease progression. Significant increases in the tumor size ( < 0.001), thickness of the affected gastric wall ( < 0.001), and depth of tumor invasion ( < 0.001) were observed in type 1 patients. Furthermore, type 1 patients had higher prevalence of affected blood vessels ( < 0.001), nerves ( < 0.001), lymph nodes ( < 0.001), and peritoneal metastasis ( < 0.001). However, no difference was found in the duration of disease between the two groups, and all deficient mismatch repairs were observed in type 1 patients.

CONCLUSIONS

The two distinct endoscopic ultrasonographic manifestations of GSRCC exhibited different clinicopathological characteristics, suggesting that they may represent different subtypes of the disease that require special attention in management strategies.

摘要

背景与目的

胃印戒细胞癌(GSRCC)有两种不同的内镜超声表现。目前尚无基于超声内镜检查的患者临床特征差异的研究报道。我们旨在研究GSRCC两种不同内镜超声表现的临床病理特征差异。

方法

本研究纳入302例经病理检查确诊并接受超声内镜检查的GSRCC患者。根据内镜超声特征,将患者分为两组:1型,全层结构消失;2型,层结构仍存在且呈淋巴瘤样表现。回顾性收集并分析临床病理特征。

结果

与2型患者相比,1型患者GSRCC发病年龄较大(P = 0.033),血清肿瘤标志物水平较高,疾病进展过程中更易出现贫血(P < 0.001)和体重减轻(P < 0.001)。1型患者肿瘤大小(P < 0.001)、受累胃壁厚度(P < 0.001)和肿瘤浸润深度(P < 0.001)显著增加。此外,1型患者血管受累(P < 0.001)、神经受累(P < 0.001)、淋巴结受累(P < 0.001)及腹膜转移(P < 0.001)的发生率更高。然而,两组患者的病程无差异,且所有错配修复缺陷均见于1型患者。

结论

GSRCC的两种不同内镜超声表现具有不同的临床病理特征,提示它们可能代表该疾病的不同亚型,在治疗策略中需要特别关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0083/12080688/a364f894da6f/eusj-13-293-g001.jpg

相似文献

1
The comparison of clinicopathological characteristics of two distinct manifestations of gastric signet ring cell carcinoma under EUS.
Endosc Ultrasound. 2024 Sep-Oct;13(5):293-299. doi: 10.1097/eus.0000000000000085. Epub 2024 Nov 8.
2
Endoscopic and clinicopathologic features of early gastric signet ring cell carcinoma ≤20 mm: a retrospective observational study.
Scand J Gastroenterol. 2023 Jan;58(1):38-44. doi: 10.1080/00365521.2022.2100227. Epub 2022 Jul 18.
3
miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression.
Biochem Biophys Res Commun. 2016 Jan 29;470(1):68-74. doi: 10.1016/j.bbrc.2015.12.116. Epub 2015 Dec 29.
5
Immunosuppressive tumor microenvironment in gastric signet-ring cell carcinoma.
World J Clin Oncol. 2024 Sep 24;15(9):1126-1131. doi: 10.5306/wjco.v15.i9.1126.
6
8
Risk Factors for Lymph Node Metastasis in Early Gastric Cancer with Signet Ring Cell Carcinoma.
J Gastrointest Surg. 2015 Nov;19(11):1958-65. doi: 10.1007/s11605-015-2915-z.
9
Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis.
World J Clin Cases. 2020 Feb 26;8(4):658-669. doi: 10.12998/wjcc.v8.i4.658.

本文引用的文献

2
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Oncogene. 2022 Jun;41(26):3455-3460. doi: 10.1038/s41388-022-02350-6. Epub 2022 May 26.
3
The updated WHO classification of digestive system tumours-gastric adenocarcinoma and dysplasia.
Pathologe. 2022 Feb;43(1):8-15. doi: 10.1007/s00292-021-01023-7. Epub 2021 Nov 22.
4
Prognosis and Biological Behavior of Gastric Signet-Ring Cell Carcinoma Better or Worse: A Meta-Analysis.
Front Oncol. 2021 Jun 30;11:603070. doi: 10.3389/fonc.2021.603070. eCollection 2021.
6
A new therapy for refractory gastric cancer bleeding: endoscopic ultrasound-guided lauromacrogol injection.
Endoscopy. 2022 Apr;54(4):E151-E152. doi: 10.1055/a-1398-5196. Epub 2021 Apr 16.
7
Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges.
Cancer Manag Res. 2020 Sep 3;12:7973-7981. doi: 10.2147/CMAR.S268032. eCollection 2020.
8
Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients.
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101454. doi: 10.1016/j.clinre.2020.05.006. Epub 2020 Jun 3.
9
Where does signet-ring cell carcinoma come from and where does it go?
Gastric Cancer. 2019 Jul;22(4):651-652. doi: 10.1007/s10120-019-00960-w. Epub 2019 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验